From Dermatology Times Higher doses of incobotulinumtoxinA (Xeomin) offer patients a longer duration of response in the treatment for glabellar frown lines, according to recently-presented clinical trial results.
More and more men are opting for dermal fillers, but often aren't satisfied with the results. To meet patient expectations, clinicians need to consider how masculine features affect cosmetic injections.
From Medical Economics Doctors can use psychological techniques like deep listening and emotional validation to make patients feel heard and understood.
Have comments or questions about the eNewsletter? Contact us!
The Aesthetic Channel editor Eliza Cabana at [email protected]
The Aesthetic Guide editor Erin Velardo at [email protected]
Channel Director Heather Onorati at [email protected]
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%